Will SARS-CoV-2 become endemic?

Reinfection, seasonality, and viral competition will shape endemic transmission patterns Reinfection, in which an individual is subject to multiple, distinct infections from the same virus species throughout their lifetime, is a salient feature of many respiratory viruses. Indeed, the persistence and ubiquity in human society of common respiratory viruses—including influenza viruses, respiratory syncytial virus (RSV), rhinovirus, and the endemic coronaviruses—are largely due to their ability to produce repeat infection. Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, a critical concern has been whether humans will experience reinfections with this pathogen, which might enable it to become endemic.

[1]  A. Monto,et al.  Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan , 2020, The Journal of infectious diseases.

[2]  N. Ferguson,et al.  The effect of antibody-dependent enhancement on the transmission dynamics and persistence of multiple-strain pathogens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Jeffrey Shaman,et al.  Absolute humidity modulates influenza survival, transmission, and seasonality , 2009, Proceedings of the National Academy of Sciences.

[4]  J. Davies,et al.  Influenza A: infection and reinfection , 1984, Journal of Hygiene.

[5]  M. Lipsitch,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[6]  M. Chan-yeung,et al.  Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance , 2006, Respirology.

[7]  E. Anderson,et al.  Reviewing and Synthesizing the State of the Science Regarding Associations between Adult Run Timing and Specific Genotypes in Chinook Salmon and Steelhead: Report of a workshop held in Seattle, Washington, 27–28 February 2020 , 2020 .

[8]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[9]  E. Walsh,et al.  Immunity to and frequency of reinfection with respiratory syncytial virus. , 1991, The Journal of infectious diseases.

[10]  K. Walters,et al.  Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Shah,et al.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.